Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient

Key clinical message Primary central nervous system lymphoma (PCNSL) remains a therapeutic challenge due to impaired drugs diffusion as a result of the blood‐brain barrier and high risk of relapse. Patients with good performance status, chemo‐sensitive disease, and eligible for autologous stem cell...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Vincent Camus, Sydney Dubois, Stéphane Lepretre, Fabrice Jardin, Hervé Tilly
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2018-08-01
Rangatū:	Clinical Case Reports
Ngā marau:	autologous stem cell transplant busulfan complete remission primary central nervous system lymphoma thiotepa
Urunga tuihono:	https://doi.org/10.1002/ccr3.1630
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!